View Item 

Show simple item record

Prospective Evaluation of Two Dosing Equations for Theophylline in Premature Infants

dc.contributor.authorBhatt‐mehta, Varshaen_US
dc.contributor.authorDonn, Steven M.en_US
dc.contributor.authorSchork, M. Anthonyen_US
dc.contributor.authorReed, Susanen_US
dc.contributor.authorJohnson, Cary E.en_US
dc.date.accessioned2012-03-16T15:55:19Z
dc.date.available2012-03-16T15:55:19Z
dc.date.issued1996-09-10en_US
dc.identifier.citationBhatt‐mehta, Varsha ; Donn, Steven M.; Schork, M. Anthony; Reed, Susan; Johnson, Cary E. (1996). "Prospective Evaluation of Two Dosing Equations for Theophylline in Premature Infants." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 16(5). <http://hdl.handle.net/2027.42/90141>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90141
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.titleProspective Evaluation of Two Dosing Equations for Theophylline in Premature Infantsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumBiostatistics, University of Michigan, Ann Arbor, Michigan.en_US
dc.contributor.affiliationumPediatrics and Communicable Diseases, Section of Neonatal‐Perinatal Medicine, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumCollege of Pharmacy and the Departments of Pharmacy, University of Michigan, Ann Arbor, Michiganen_US
dc.identifier.pmid8888073en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90141/1/j.1875-9114.1996.tb02995.x.pdf
dc.identifier.doi10.1002/j.1875-9114.1996.tb02995.xen_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceGilman JT, Gal P, Levine RS, Hersh CB, Erkan NV. Factors influencing theophylline disposition in 179 newborn infants. Ther Drug Monit 1986; 8: 4 – 10.en_US
dc.identifier.citedreferenceMoore ES, Faix RG, Banagale RC et al. The population pharmacokinetics of theophylline in neonates and young infants. J Pharmacokinet Biopharm 1989; 17: 47 – 66.en_US
dc.identifier.citedreferenceJones RAK, Baillie E. Dosage schedule for iv aminophylline in apnoea of prematurity, based on pharmacokinetic studies. Arch Dis Child 1979; 54: 190 – 3.en_US
dc.identifier.citedreferenceBhatt‐Mehta V, Johnson CE, Donn SM, Theisen V. Accuracy and reliability of dosing equations to individualize theophylline treatment in apnea of prematurity. Pharmacotherapy 1995; 15: 246 – 50.en_US
dc.identifier.citedreferenceNassif EG, Weinberger MN, Shannon D et al. Theophylline disposition in infancy. J Pediatr 1981; 98: 158 – 60.en_US
dc.identifier.citedreferenceAnonymous. Theophylline. In: Rowe PC ed.. Johns Hopkins, the Harriet Lane handbook, 12th ed. Chicago: Year Book, 1991: 237.en_US
dc.identifier.citedreferenceViscardi RM, Faix RG, Nicks JJ, Grasela TH. Efficacy of theophylline for prevention of post‐extubation respiratory failure in very low birth weight infants. J Pediatr 1985; 107: 469 – 72.en_US
dc.identifier.citedreferenceHendeles L, Weinberger M, Johnson G. Theophylline. In: Evans WE, Schentag JJ, Jusko WJ eds.. Applied pharmacokinetics. San Francisco: Applied Therapeutics, 1980: 95 – 138.en_US
dc.identifier.citedreferenceDonn SM, Roloff DW, Goldstein GW. Prevention of intraventricular hemorrhage in preterm infants by phenobarbitone. Lancet 1981; 2: 215 – 17.en_US
dc.identifier.citedreferenceAnonymous. Use of theophylline in infants. FDA Drug Bull 1985; 15: 16 – 17.en_US
dc.identifier.citedreferenceLonnerholm G, Lindstrom B, Paalow L, Sedin G. Serum theophylline and caffeine clearance during first year of life. Eur J Clin Pharmacol 1983; 24: 371 – 80.en_US
dc.identifier.citedreferenceBada HS, Khanna NN, Somani SM, Tin TT. Interconversion of theophylline and caffeine in newborn infants. J Pediatr 1979; 94: 993 – 5.en_US
dc.identifier.citedreferenceGilman JT, Gal P. Inadequacy of FDA guidelines for theophylline use in neonates. Drug Intell Clin Pharm 1986; 20: 481 – 4.en_US
dc.identifier.citedreferenceMurphy JE, Erkan NV, Fakhreddine F. New FDA guidelines for theophylline dosing in infants [letter]. Clin Pharm 1986; 5: 16.en_US
dc.identifier.citedreferenceHogue SL, Phelps SJ. Evaluation of three dosing equations in infants less than or equal to one year of age. Clin Res 1990; 38: 982A.en_US
dc.identifier.citedreferenceLanday RA, Gonzalez MA, Taylor JC. Effect of phenobarbital on theophylline disposition. J Allergy Clin Immunol 1978; 62: 27 – 9.en_US
dc.identifier.citedreferenceYeung CY, Tam LS, Chan A, Lee KH. Phenobarbitone prophylaxis for neonatal hyperbilirubinemia. Pediatrics 1971; 48: 372 – 6.en_US
dc.identifier.citedreferenceValdes OS, Maurer HM, Shumway CN, Draper DA, Hossaini AA. Controlled clinical trial of phenobarbital and/or light in reducing neonatal hyperbilirubinemia in a predominantly negro population. J Pediatr 1971; 79: 1015 – 17.en_US
dc.identifier.citedreferenceAranda JV, Grondin D, Sasynick BI. Pharmacologic considerations in the therapy of neonatal apnea. Pediatr Clin North Am 1981; 28: 113 – 33.en_US
dc.identifier.citedreferenceGrasela TH, Donn SM. Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data. Dev Pharmacol Ther 1985; 8: 374 – 83.en_US
dc.identifier.citedreferenceTserg K, Takieddine FN, King KC. Developmental aspects of theophylline metabolism in premature infants. Clin Pharmacol Ther 1983; 33: 522 – 8.en_US
dc.identifier.citedreferenceShannon DC, Gotay F, Stein IM, Rogers MC, Todres ID, Moylan FMB. Prevention of apnea and bradycardia in low birth weight infants. Pediatrics 1975: 55: 589 – 94.en_US
dc.identifier.citedreferenceAlden ER, Mandelkorn T, Woodrum DE, Wennberg RP, Parks CR, Hodson WA. Morbidity and mortality of infants weighing less than 1000 grams in an intensive care nursery. Pediatrics 1972; 50: 40 – 9.en_US
dc.identifier.citedreferenceDaily WJR, Klaus M. Apnea in premature infants: monitoring, incidence, heart rate changes, and effect of environmental temperature. Pediatrics 1969; 43: 510 – 18.en_US
dc.identifier.citedreferenceHenderson‐Smart DJ, Pettigrew AG, Campbell DJ. Clinical apnea and brainstem neural function in preterm infants. N Engl J Med 1983; 308: 353 – 7.en_US
dc.identifier.citedreferenceMartin RJ, Miller MJ, Carlo WA. Pathogenesis of apnea in preterm infants. J Pediatr 1986; 109: 733 – 41.en_US
dc.identifier.citedreferenceGerhardt T, McCarthy J, Bancalari E. Effect of aminophylline on respiratory center and reflex activity in premature infants with apnea. Pediatr Res 1983; 17: 199 – 201.en_US
dc.identifier.citedreferenceUauy R, Shapiro DL, Smith B, Warshaw JB. Treatment of severe apnea in prematures with orally administered theophylline. Pediatrics 1975; 55: 595 – 8.en_US
dc.identifier.citedreferenceDavi MJ, Sankaran K, Simons KJ et al. Physiologic changes induced by theophylline in the treatment of apnea in preterm infants. J Pediatr 1978; 92: 91 – 5.en_US
dc.identifier.citedreferencePeabody J, Neese AL, Lucey JF et al. Decreased hypoxic, hyperoxic and bradycardic episodes as responses of neonates to theophylline. Pediatr Res 1977; 11: 419.en_US
dc.identifier.citedreferenceAranda JV, Sitar DS, Parsons WD et al. Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 1976; 295: 413 – 16.en_US
dc.identifier.citedreferenceGiacoia G, Jusko WJ, Menke J et al. Theophylline pharmacokinetics in premature infants with apnea. J Pediatr 1976; 89: 829 – 32.en_US
dc.identifier.citedreferenceCummiskey JM, Popa V. State‐of‐the‐art: pharmacologic‐therapeutic update, theophyllines: a review. J Asthma 1984; 21: 243 – 57.en_US
dc.identifier.citedreferenceStile IL, Zolfaghari S, Hiatt IM et al. Pharmacokinetics of theophylline in premature infants on the first day of life. Clin Ther 1986; 8: 336 – 41.en_US
dc.identifier.citedreferenceTakieddine FN, Tserng K, King KC et al. Postnatal development of theophylline metabolism in preterm infants. Semin Perinatol 1981; 5: 351 – 8.en_US
dc.identifier.citedreferenceEstelle F, Simons R, Rigatto H et al. Pharmacokinetics of theophylline in neonates. Semin Perinatol 1981; 5: 337 – 45.en_US
dc.identifier.citedreferenceKraus DM, Fischer JH, Reitz SJ et al. Alterations in theophylline metabolism during the first year of life. Clin Pharmacol Ther 1993; 54: 351 – 9.en_US
dc.identifier.citedreferenceGal P, Boer H, Toback J et al. Effect of asphyxia on theophylline clearance in newborns. South Med J 1982; 75: 836 – 8.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1875-9114.1996.tb02995.x.pdf
Size:
750.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.